Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells
Authors
Keywords
-
Journal
PROTEIN ENGINEERING DESIGN & SELECTION
Volume 27, Issue 3, Pages 83-88
Publisher
Oxford University Press (OUP)
Online
2014-01-14
DOI
10.1093/protein/gzt065
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pertuzumab for the treatment of human epidermal growth factor receptor type 2-positive metastatic breast cancer
- (2013) C. Chung et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Effects of a human compact anti-ErbB2 antibody on gastric cancer
- (2013) Carmine Fedele et al. Gastric Cancer
- Antibody-Drug Conjugates in Cancer Therapy
- (2012) Eric L. Sievers et al. Annual Review of Medicine
- Mechanisms of cardiotoxicity associated with ErbB2 inhibitors
- (2012) Carmine Fedele et al. BREAST CANCER RESEARCH AND TREATMENT
- A novel fully human antitumor ImmunoRNase resistant to the RNase inhibitor
- (2012) G. Riccio et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab
- (2011) D. Lenihan et al. ANNALS OF ONCOLOGY
- Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors
- (2011) Carmine Fedele et al. BREAST CANCER RESEARCH AND TREATMENT
- A novel fully human antitumour immunoRNase targeting ErbB2-positive tumours
- (2011) M Borriello et al. BRITISH JOURNAL OF CANCER
- A novel ErbB2 epitope targeted by human antitumor immunoagents
- (2011) Fulvia Troise et al. FEBS Journal
- Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours
- (2010) T Gelardi et al. BRITISH JOURNAL OF CANCER
- Trastuzumab for gastric cancer treatment
- (2010) Alicia FC Okines et al. LANCET
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents
- (2009) Gennaro Riccio et al. FASEB JOURNAL
- Human anti-ErbB2 immunoagents - immunoRNases and compact antibodies
- (2009) Claudia De Lorenzo et al. FEBS Journal
- From ImmunoToxins to ImmunoRNases
- (2008) Claudia Lorenzo et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started